NASDAQ Slips Down 0.4% But Biotech Sector Hits New Highs

source link The ETF IBB (142.62) hit an all time high today and is up 36.6% YTD. The low for IBB over two years was August 19, 2011 at $88.50. Our mid-cap biopharma index is up 0.8% with big winners in JAZZ ($54.65) and Exelixis (EXEL $5.40) and Medivation (MDVN $106.27).

Diagnostics and tools got some M&A action with the acquisition of IRIS ($19.49) by Danaher(DHR $54.9) confirming a trend of major life science tools companies acquiring diagnostic companies.

Rayno Life Science movers: Alexion (ALXN $100 new high) up 0.3%, Gilead (GILD $65.14 ) up 5%, and Regeneron (REGN $150.36) up 0.4%.




No comments yet.

Leave a Reply